| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/18/1998 | CA2271749A1 8-azabicyclo¬3.2.1|octane-, 8-azabicyclo¬3.2.1|oct-6-ene-, 9-azabicyclo¬3.3.1|nonane-, 9-aza-3-oxabicyclo¬3.3.1|nonane- and 9-aza-3-thiabicyclo¬3.3.1|nonane derivatives, their preparation and their use as insecticides |
| 06/18/1998 | CA2269681A1 Use of a 6-aryl pyrimidine compound for treating multiple sclerosis |
| 06/18/1998 | CA2269680A1 An oil composition of dihydropolyprenols |
| 06/18/1998 | CA2263886A1 Method for treating and preventing heart failure and ventricular dilatation |
| 06/18/1998 | CA2250221A1 Pharmaceutical compositions containing alendronate and an agent promoting gastric emptying |
| 06/18/1998 | CA2246306A1 Use of lipophilic antioxidant compounds to prevent retinoid induced, uva-mediated oxidative reactions |
| 06/18/1998 | CA2245956A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof |
| 06/17/1998 | EP0848061A2 Self-enhancing, pharmacologically controllable expression systems |
| 06/17/1998 | EP0848010A1 Novel anthracycline derivatives having 4-amino-2,4,6-trideoxy-2-fluoro-alpha-L-talopyranosyl group |
| 06/17/1998 | EP0848008A1 Organotin compounds and compositions containing these compounds |
| 06/17/1998 | EP0848001A1 Crystalline form of the doxazosin mesylate and process for its production |
| 06/17/1998 | EP0847999A1 N-benzylpiperazine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 06/17/1998 | EP0847996A1 Sulfonamide substituted compounds as K-channel blockers |
| 06/17/1998 | EP0847990A1 4-(C1-C4)-Alkoxy-3-pyrrolin-2-on-1-yl-acetic acid derivatives, their preparation and use in the synthesis of 4-hydroxy-2-oxo-pyrrolidin-1-yl-acetamide |
| 06/17/1998 | EP0847986A1 Esterified hydroxypropylated quaternary ammonium compounds, cosmetic and dermatologic compostions containing them |
| 06/17/1998 | EP0847756A1 Plant extracts for the preparation of pharmaceutical compositions for the treatment of hepatitis |
| 06/17/1998 | EP0847755A1 Use of an extract of cimicifuga racemosa |
| 06/17/1998 | EP0847754A1 Anticarcinogenic drug composition |
| 06/17/1998 | EP0847446A1 PRODUCTION OF BETA-GLUCAN-MANNAN PREPARATIONS BY AUTOLYSIS OF CELLS UNDER CERTAIN pH, TEMPERATURE AND TIME CONDITIONS |
| 06/17/1998 | EP0847443A1 Crystalline zap family proteins |
| 06/17/1998 | EP0847402A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
| 06/17/1998 | EP0847397A1 Novel water-soluble c-ring analogues of 20 (s)-camptothecin |
| 06/17/1998 | EP0847395A1 Pyrrolyl tetrahydroquinoxalin diones, their production and use in the treatment of diseases |
| 06/17/1998 | EP0847391A1 Aromatic compounds and pharmaceutical compositions containing them |
| 06/17/1998 | EP0847379A1 Phenoxy acetic acids as aldose reductase inhibitors and antihyperglycemic agents |
| 06/17/1998 | EP0847277A1 Treatment of ocular inflammatory conditions with interleukin-10 |
| 06/17/1998 | EP0847276A2 Method for effecting vasodilation with (1,5-inter)aryl prostaglandin derivatives |
| 06/17/1998 | EP0847275A1 Regulation of intracellular glucocorticoid concentrations |
| 06/17/1998 | EP0847272A2 LIPOSOMAL PHOSPHODIESTER, PHOSPHOROTHIOATE, AND p-ETHOXY OLIGONUCLEOTIDES |
| 06/17/1998 | EP0847242A1 Sugar-free dragee-like products |
| 06/17/1998 | EP0847240A1 Novel embolizing compositions |
| 06/17/1998 | EP0847239A2 Improved method for controlling ectoparasites |
| 06/17/1998 | EP0789697B1 CRYSTAL FORM OF ANHYDROUS 7-((1a,5a, 6a)-6-AMINO-3-AZABICYCLO ( 3.1. 0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT |
| 06/17/1998 | EP0714389B1 Amide and urea derivatives as 5ht1d receptor antagonists |
| 06/17/1998 | EP0713383B1 Sunscreen agents |
| 06/17/1998 | EP0689549B1 New urea derivates, their preparation and their use |
| 06/17/1998 | EP0666847B1 Tryptamine analogs with 5-ht1d selectivity |
| 06/17/1998 | EP0635003B1 Perhydroisoindole derivatives as p substance antagonists |
| 06/17/1998 | EP0580633B1 Heterocyclic amines useful in the therapy of asthma and inflammation of the respiratory tract |
| 06/17/1998 | CN1185173A Method for microbial regulation |
| 06/17/1998 | CN1185158A Prepn. of clavulanate salts |
| 06/17/1998 | CN1185156A Novel substituted tetrahydropyrano £3, 2-d| oxazolones, the prodn. and pharmaceutical use thereof |
| 06/17/1998 | CN1185153A Benzopyrans and pharmaceutical composition contg. same |
| 06/17/1998 | CN1185152A Pyrrolidinyl methyl indole salt |
| 06/17/1998 | CN1185147A Amide derivatives an external skin or Hair care prepn. |
| 06/17/1998 | CN1185112A Use of flavanolignanes for the prepn. of medicametns with antiproliferative activity in uterus, ovary and breast |
| 06/17/1998 | CN1185110A Synergistic combination of zidovudine |
| 06/17/1998 | CN1185109A Use of vitamin D2 or vitamin D4 derivatives for mfg. medicament for treating secondary hyperparathyroidism |
| 06/17/1998 | CN1185108A Method for treating cognitive dysfunction |
| 06/17/1998 | CN1185107A Pharmaceutical composition contg. proton pump inhititors |
| 06/17/1998 | CN1185106A Use of carbazole compounds for treating congestive heart failure |
| 06/17/1998 | CN1185104A Diltiazem controlled release formulation |
| 06/17/1998 | CN1184815A Cephalosporin pyridinium derinvatives |
| 06/17/1998 | CN1184662A Powder for removing toxic substances and promoting granulation |
| 06/17/1998 | CN1184636A Formulation for iron chelation process for preparing formulation |
| 06/17/1998 | CN1184635A Pharmaceutical compositions and methods for modulating signal transduction |
| 06/17/1998 | CN1184634A Omega -3 capsule and method for preparing same |
| 06/17/1998 | CN1184633A Lotion for radical treatment of tinea manuum and tinea pedis |
| 06/17/1998 | CN1038753C Method for prepn. of glucan iron |
| 06/17/1998 | CN1038750C Deoxy hexose monosaccharides having a saturated nitrogen-contg. heterocyclic |
| 06/17/1998 | CN1038749C Method for prepn. of dibenz £b, f| £1, 4| oxazepin -11 (10H)-ones |
| 06/17/1998 | CN1038748C Method for prepn. of sulfonamide fibrinogen receptor antagonists |
| 06/17/1998 | CN1038726C Analgin nasal drops |
| 06/17/1998 | CA2224835A1 Pharmaceutical compounds |
| 06/16/1998 | US5767293 Antitumor |
| 06/16/1998 | US5767285 Linkers useful for the synthesis of conjugates of methyltrithio antitumor agents |
| 06/16/1998 | US5767283 Chemical intermediate for 7-n-organosulfonyl-1h-indole derivative antitumor agents; nontoxic |
| 06/16/1998 | US5767280 Hydroxylation of a thio-substituted 1,2,5-thiadiazole with an aqueous alkaline metal hydroxide; acidification |
| 06/16/1998 | US5767274 Treating tumors or restenosis |
| 06/16/1998 | US5767268 Treatment of disorders characterized by excessive or destructive proliferation of smooth muscle cells |
| 06/16/1998 | US5767262 Isolated dna comprising sequence encoding smooth muscle cell lim polypeptide |
| 06/16/1998 | US5767251 Polypeptides |
| 06/16/1998 | US5767242 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 06/16/1998 | US5767164 Use of deprenyl to rescue damaged nerve cells |
| 06/16/1998 | US5767163 Lubricating and/or germicidal composition |
| 06/16/1998 | US5767162 Tri-and tetra-substituted guanidines and their use as excitatory amino acid antagonists |
| 06/16/1998 | US5767161 Ibuprofen, ethanol, propylene glycol |
| 06/16/1998 | US5767160 Method and formulation of stimulating nitric oxide synthesis |
| 06/16/1998 | US5767159 Improving the capacity of muscles for work and shortening the time for recovery after exercise or various therapies, e.g.postoperative surgery, respiratory disorders |
| 06/16/1998 | US5767157 Arthritic pain prevention method and compositions |
| 06/16/1998 | US5767156 Polyunsaturated fatty acids and uses thereof |
| 06/16/1998 | US5767155 Contacting ventricular muscle cells with retinoic acid compound which binds retinoic acid receptors |
| 06/16/1998 | US5767154 5-trans-prostaglandins of the F series and their use as ocular hypotensives |
| 06/16/1998 | US5767152 Composition and methods for stimulating hair growth |
| 06/16/1998 | US5767149 α-glycosyl-L-ascorbic acid, and it's preparation and uses |
| 06/16/1998 | US5767148 4-((5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl) carbonylbenzoic acid ethylene acetal and 4-((5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl) carboxylamidobenzoic acid having retinoid activityp; leukemia |
| 06/16/1998 | US5767146 Benzoate substituted chromene derivative; treatment of osteoporosis |
| 06/16/1998 | US5767143 Eye drops containing single polymer, pilocarpine, beta-blocking agent, carrier, having specified ph and viscosity |
| 06/16/1998 | US5767141 Substituted propane derivatives, a process for their preparation and the use of the compounds for treating diseases |
| 06/16/1998 | US5767140 5,5-Disubstituted hydantoins |
| 06/16/1998 | US5767139 Skin disorders; alopecia; prostate cancer |
| 06/16/1998 | US5767138 Pharmaceutical composition for inhibiting the growth of viruses and cancers |
| 06/16/1998 | US5767136 Administering to reduce migration of cells, reduce build up of connective tissue, or prevent lipid accumulation in the blood vessels |
| 06/16/1998 | US5767135 Antiviral agent |
| 06/16/1998 | US5767134 Antitumor agents |
| 06/16/1998 | US5767133 Secondary amines as antidiabetic and antiobesity agents |
| 06/16/1998 | US5767132 Pyridyl chroman |
| 06/16/1998 | US5767130 Use of kainic acid antagonists to prevent toxic side effects of NMDA antagonists |
| 06/16/1998 | US5767128 1,3-dihydro-2H-pyrrolo 2,3-b!pyridin-2-one compounds |
| 06/16/1998 | US5767127 Optically active pyridonecarboxylic acid derivatives |